| 注册
首页|期刊导航|中国临床康复|海风藤选择性抑制淀粉样前体蛋白基因表达

海风藤选择性抑制淀粉样前体蛋白基因表达

韩恩吉 胡洪涛 何秀全 邓小梅 卢勇 周海涛

中国临床康复2004,Vol.8Issue(13):2592-2593,2.
中国临床康复2004,Vol.8Issue(13):2592-2593,2.

海风藤选择性抑制淀粉样前体蛋白基因表达

Selective inhibition of haifengteng in gene expression of beta-amyloid precursor protein

韩恩吉 1胡洪涛 1何秀全 2邓小梅 1卢勇 3周海涛3

作者信息

  • 1. 山东大学,齐鲁医院神经内科,山东省,济南市,250012
  • 2. 山东大学,医学院组织胚胎教研室,山东省,济南市,250012
  • 3. 山东大学,医学院遗传学教研室,山东省,济南市,250012
  • 折叠

摘要

Abstract

BACKGROUND: Beta-amyloid protein(β-AP) is a core element in senile plague and its cerebral deposition closely relates to the onset of Alzheimer' s disease(AD) . Modern researches prove that β-AP is originated form beta-amyloid precursor protein(β-APP) . If the gene expression of β-APP can be inhibited, the cerebral deposition of β-AP will decrease, and therefore, AD might be treated effectively. Hence, many national and international scholars are actively searching for the inhibitors that could inhibit the gene expression of β-APP for effective medications in AD treatment.OBJECTIVE: To study the impact of haifengteng on gene expression of β-APP in the cells of human neuroblastoma.DESIGN: Experimental control: medication intervention(haifengteng) and non-medication intervention. Gene comparison between objective gene (β-APP) and structure gene (β-Acfin).MATERIALS: Cellular serials of human neuroblastoma(SK-N-SH),haifengteng.METHODS: To observe the impact of haifengteng in different reactive strength and different reactive time on β-APP mRNA through cellular culture and RT-PCR.RESULTS: Haifengteng could selectively inhibit the gene expression of β-APP and the inhibition enhanced along with the prolongation of the reactive time and the increase of the reactive strength.CONCLUSION: The selective inhibition of haifengteng in gene expression of β-APP provides a more reliable laboratorial basis in AD prevention and treatment.

关键词

阿尔茨海默病/海风藤/基因

分类

医药卫生

引用本文复制引用

韩恩吉,胡洪涛,何秀全,邓小梅,卢勇,周海涛..海风藤选择性抑制淀粉样前体蛋白基因表达[J].中国临床康复,2004,8(13):2592-2593,2.

基金项目

国家自然科学基金(3027164) (3027164)

国家中医药管理局课题(97Z301) (97Z301)

中国临床康复

OA北大核心CSTPCD

2095-4344

访问量0
|
下载量0
段落导航相关论文